IL80960A0 - Process for improving the expression of eukaryotic proteins - Google Patents

Process for improving the expression of eukaryotic proteins

Info

Publication number
IL80960A0
IL80960A0 IL80960A IL8096086A IL80960A0 IL 80960 A0 IL80960 A0 IL 80960A0 IL 80960 A IL80960 A IL 80960A IL 8096086 A IL8096086 A IL 8096086A IL 80960 A0 IL80960 A0 IL 80960A0
Authority
IL
Israel
Prior art keywords
expression
cdna
improving
eucaryotic
eukaryotic proteins
Prior art date
Application number
IL80960A
Other languages
English (en)
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL80960A0 publication Critical patent/IL80960A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/03—Automatic limiting or abutting means, e.g. for safety
    • A61B2090/033—Abutting means, stops, e.g. abutting on tissue or skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/06—Measuring instruments not otherwise provided for
    • A61B2090/062—Measuring instruments not otherwise provided for penetration depth

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Networks Using Active Elements (AREA)
  • Saccharide Compounds (AREA)
IL80960A 1985-12-19 1986-12-15 Process for improving the expression of eukaryotic proteins IL80960A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853545126 DE3545126A1 (de) 1985-12-19 1985-12-19 Verfahren zur verbesserung der expression von eukaryontenprotein

Publications (1)

Publication Number Publication Date
IL80960A0 true IL80960A0 (en) 1987-03-31

Family

ID=6288962

Family Applications (1)

Application Number Title Priority Date Filing Date
IL80960A IL80960A0 (en) 1985-12-19 1986-12-15 Process for improving the expression of eukaryotic proteins

Country Status (14)

Country Link
EP (2) EP0250513B1 (fr)
JP (1) JPS62502942A (fr)
KR (1) KR880700855A (fr)
AT (1) ATE67242T1 (fr)
AU (1) AU600253B2 (fr)
DE (2) DE3545126A1 (fr)
DK (1) DK432987D0 (fr)
ES (1) ES2026206T3 (fr)
FI (1) FI873572A (fr)
GR (1) GR3003301T3 (fr)
IL (1) IL80960A0 (fr)
PT (1) PT83968B (fr)
WO (1) WO1987003904A1 (fr)
ZA (1) ZA869487B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988005466A2 (fr) * 1987-01-15 1988-07-28 Codon Vecteurs d'expression eukaryotique de genes en tandem
US5024939A (en) * 1987-07-09 1991-06-18 Genentech, Inc. Transient expression system for producing recombinant protein
DE3730246A1 (de) * 1987-09-09 1989-06-01 Boehringer Mannheim Gmbh Expressionsvektor und verfahren zur expression von heterologen proteinen in saeugerzellen
CA2018676C (fr) * 1989-06-20 2003-05-06 Christie A. Kelton Methodes de production de proteines heteropolymeriques
FR2650838A1 (fr) * 1989-08-09 1991-02-15 Transgene Sa Vecteurs d'expression du facteur ix dans une cellule eucaryote superieure, procede de preparation de facteur ix par des animaux transgeniques et facteur ix obtenu
EP0451700A1 (fr) * 1990-04-10 1991-10-16 Miles Inc. Minigènes APP recombinants pour l'expression dans des souris transgéniques comme modèles de la maladie d'Alzheimer
AU1180692A (en) * 1991-01-29 1992-08-27 Teijin Limited Human protein c expression vector
US5858784A (en) * 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
US6627615B1 (en) 1991-12-17 2003-09-30 The Regents Of The University Of California Methods and compositions for in vivo gene therapy
US5756353A (en) * 1991-12-17 1998-05-26 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol-and liposome-based delivery
US6806084B1 (en) 1992-06-04 2004-10-19 The Regents Of The University Of California Methods for compositions for in vivo gene delivery
CA2134773A1 (fr) * 1992-06-04 1993-12-09 Robert J. Debs Methodes et compositions pour genotherapie in vivo
US6027888A (en) * 1996-04-05 2000-02-22 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells
EP1669454A3 (fr) * 1996-06-27 2009-04-01 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo ADN génomique codant pour un polypeptide capable d'induire la production d'interféron-gamma
AU735763B2 (en) * 1997-12-05 2001-07-12 Immune Response Corporation, The Novel vectors and genes exhibiting increased expression
SE9901339D0 (sv) * 1999-04-15 1999-04-15 Astra Ab New expression systems
GB201106380D0 (en) 2011-04-15 2011-06-01 Nokia Corp An apparatus, method, computer program and user interface

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534273B1 (fr) * 1982-10-07 1985-09-13 Pasteur Institut Lignees cellulaires originaires de mammiferes superieurs, productrices d'hormone de croissance, de preference humaine, et vecteurs pour leur obtention
FR2535243B1 (fr) * 1982-11-03 1986-04-04 Fives Cail Babcock Procede de fabrication d'un cylindre, notamment pour moulin a cannes, et cylindre obtenu par ce procede
IL71691A (en) * 1984-04-27 1991-04-15 Yeda Res & Dev Production of interferon-ypsilon
DE3676604D1 (de) * 1985-03-22 1991-02-07 Chiron Corp Expression von epa in saeugetierzellen.
GB2197321B (en) * 1986-09-12 1990-10-03 Genentech Inc Method and vectors for obtaining continuous production of heterologous protein in a eukaryotic host cell line

Also Published As

Publication number Publication date
ES2026206T3 (es) 1992-04-16
DE3681446D1 (de) 1991-10-17
DK432987A (da) 1987-08-19
EP0250513A1 (fr) 1988-01-07
PT83968B (pt) 1989-01-17
DE3545126A1 (de) 1987-06-25
EP0250513B1 (fr) 1991-09-11
EP0227064A1 (fr) 1987-07-01
ATE67242T1 (de) 1991-09-15
PT83968A (de) 1987-01-01
WO1987003904A1 (fr) 1987-07-02
FI873572A0 (fi) 1987-08-18
DK432987D0 (da) 1987-08-19
JPS62502942A (ja) 1987-11-26
GR3003301T3 (en) 1993-02-17
ZA869487B (en) 1987-09-30
FI873572A (fi) 1987-08-18
KR880700855A (ko) 1988-04-12
AU600253B2 (en) 1990-08-09
AU6833387A (en) 1987-07-15

Similar Documents

Publication Publication Date Title
IL80960A0 (en) Process for improving the expression of eukaryotic proteins
GB8405129D0 (en) Yeast promoter
DE3479321D1 (en) Biosynthetically produced human nerve growth factor, process for producing it, compositions containing it, dna sequence encoding it, vectors containing the sequence and host cells transformed thereby
EP0174367A4 (fr) Hotes et procedes de production de produits recombinants en grandes quantites.
DE3880468D1 (de) Rekombinante dns-expressionsvektoren.
IE820069L (en) Recombinant dna encoding a polypeptide
UA27706C2 (uk) Спосіб одержання гетерологічного поліпептиду
YU45128B (en) Process for producing functional human urochinase proteins
EP0088166A3 (en) Method for expressing a gene
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
GR3024002T3 (en) Recombinant DNA method and host cells
EP0182448A3 (fr) Production de facteur VIII et produits apparentés
ES8606490A1 (es) Un derivado de polipeptido de interferon-a humano
HUT56884A (en) Process for producing protein having urate oxidase activity, gene coding for it, expression vector, microorganisms and transformed cells
AU551490B2 (en) Dna code for protein to suppress abnormal protein degradation
ZA915211B (en) Cloned n-methylhydantoinase
CA1312566C (en) Method for increasing the expression of polypeptides in recombinant cell culture
NZ332555A (en) Gene expression in monocytes and macrophages associated with the CD68 gene
EP0064681A3 (fr) ADN recombinant
EP0183272A3 (en) Vector capable of efficient gene expression and utilization of such vector